These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21751919)

  • 1. Dalteparin in critically ill patients.
    Smythe MA; Koerber JM
    N Engl J Med; 2011 Jul; 365(2):179-80; author reply 180. PubMed ID: 21751919
    [No Abstract]   [Full Text] [Related]  

  • 2. Dalteparin versus unfractionated heparin in critically ill patients.
    ; Cook D; Meade M; Guyatt G; Walter S; Heels-Ansdell D; Warkentin TE; Zytaruk N; Crowther M; Geerts W; Cooper DJ; Vallance S; Qushmaq I; Rocha M; Berwanger O; Vlahakis NE
    N Engl J Med; 2011 Apr; 364(14):1305-14. PubMed ID: 21417952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dalteparin and heparin-induced thrombocytopenia.
    Davidson BL
    N Engl J Med; 2011 Sep; 365(12):1158; author reply 1158. PubMed ID: 21992138
    [No Abstract]   [Full Text] [Related]  

  • 4. Dalteparin in critically ill patients.
    Esterbrook G; Hart S
    N Engl J Med; 2011 Jul; 365(2):179; author reply 180. PubMed ID: 21751920
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost-effectiveness of dalteparin vs unfractionated heparin for the prevention of venous thromboembolism in critically ill patients.
    Fowler RA; Mittmann N; Geerts W; Heels-Ansdell D; Gould MK; Guyatt G; Krahn M; Finfer S; Pinto R; Chan B; Ormanidhi O; Arabi Y; Qushmaq I; Rocha MG; Dodek P; McIntyre L; Hall R; Ferguson ND; Mehta S; Marshall JC; Doig CJ; Muscedere J; Jacka MJ; Klinger JR; Vlahakis N; Orford N; Seppelt I; Skrobik YK; Sud S; Cade JF; Cooper J; Cook D; ;
    JAMA; 2014 Nov; 312(20):2135-45. PubMed ID: 25362228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin-induced thrombocytopenia in medical surgical critical illness.
    Warkentin TE; Sheppard JI; Heels-Ansdell D; Marshall JC; McIntyre L; Rocha MG; Mehta S; Davies AR; Bersten AD; Crozier TM; Ernest D; Vlahakis NE; Hall RI; Wood GG; Poirier G; Crowther MA; Cook DJ;
    Chest; 2013 Sep; 144(3):848-858. PubMed ID: 23722881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin-induced thrombocytopenia in critically ill patients.
    Warkentin TE
    Crit Care Clin; 2011 Oct; 27(4):805-23, v. PubMed ID: 22082515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors and impact of major bleeding in critically ill patients receiving heparin thromboprophylaxis.
    Lauzier F; Arnold DM; Rabbat C; Heels-Ansdell D; Zarychanski R; Dodek P; Ashley BJ; Albert M; Khwaja K; Ostermann M; Skrobik Y; Fowler R; McIntyre L; Nates JL; Karachi T; Lopes RD; Zytaruk N; Finfer S; Crowther M; Cook D
    Intensive Care Med; 2013 Dec; 39(12):2135-43. PubMed ID: 23942857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compliance with platelet count monitoring recommendations and management of possible heparin-induced thrombocytopenia in hospitalized patients receiving low-molecular-weight heparin.
    ten Berg MJ; van den Bemt PM; Huisman A; Schobben AF; Egberts TC; van Solinge WW
    Ann Pharmacother; 2009 Sep; 43(9):1405-12. PubMed ID: 19690229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dalteparin vs warfarin in hip arthroplasty patients.
    Bajjoka AE
    Arch Intern Med; 2001 Mar; 161(5):776-8. PubMed ID: 11231726
    [No Abstract]   [Full Text] [Related]  

  • 11. Current practice of thromboprophylaxis in the burn population: a survey study of 84 US burn centers.
    Ferguson RE; Critchfield A; Leclaire A; Ajkay N; Vasconez HC
    Burns; 2005 Dec; 31(8):964-6. PubMed ID: 16269216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dalteparin thromboprophylaxis for critically ill medical-surgical patients with renal insufficiency.
    Rabbat CG; Cook DJ; Crowther MA; McDonald E; Clarke F; Meade MO; Lee KA; Cook RJ
    J Crit Care; 2005 Dec; 20(4):357-63. PubMed ID: 16310608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe and persistent heparin-induced thrombocytopenia despite fondaparinux treatment.
    Tvito A; Bakchoul T; Rowe JM; Greinacher A; Ganzel C
    Am J Hematol; 2015 Jul; 90(7):675-8. PubMed ID: 25683147
    [No Abstract]   [Full Text] [Related]  

  • 14. [Economic analysis of dalteparin use in knee surgery at Instituto Mexicano del Seguro Social].
    Arreola-Ornelas H; Rosado-Buzzo A; García-Mollinedo L; Dorantes Aguilar J; Muciño-Ortega E; Mould-Quevedo JF
    Cir Cir; 2012; 80(5):411-8. PubMed ID: 23351443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dalteparin new treatment duration: new dosage. Is prolonged prophylaxis needed?
    Prescrire Int; 2000 Feb; 9(45):197-8. PubMed ID: 11503794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer.
    Lee AY; Levine MN; Baker RI; Bowden C; Kakkar AK; Prins M; Rickles FR; Julian JA; Haley S; Kovacs MJ; Gent M;
    N Engl J Med; 2003 Jul; 349(2):146-53. PubMed ID: 12853587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk assessment and prophylaxis of venous thromboembolism in acutely and/or critically ill patients.
    Davidson BL
    Haemostasis; 2000; 30 Suppl 2():77-81; discussion 63. PubMed ID: 11251346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients.
    Leizorovicz A; Cohen AT; Turpie AG; Olsson CG; Vaitkus PT; Goldhaber SZ;
    Circulation; 2004 Aug; 110(7):874-9. PubMed ID: 15289368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Think of HIT when thrombosis follows heparin.
    Warkentin TE
    Chest; 2006 Sep; 130(3):631-2. PubMed ID: 16963651
    [No Abstract]   [Full Text] [Related]  

  • 20. [Thrombocytopenia can be HIT. Heparin treatment can cause low life-threatening thrombocyte levels].
    Själander A; Johansson L; Hillarp A; Bergqvist D; Tengborn L; Svensson P
    Lakartidningen; 2009 Mar 4-10; 106(10):682-5. PubMed ID: 19418688
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.